New blood test might be a breakthrough in skin cancer treatment.
The deputy executive director of NASTAD talks the future of HIV treatment and prevention and the epidemic in the South.
In late-stage studies, dolutegravir and lamivudine demonstrate the ability to replace a 3-drug regimen to control HIV.
A study team’s lead investigator explains how the infection of HIV in the female anatomy occurs after heterosexual sex.
Indianapolis health researchers hope the results of a new study will encourage policymakers to support nationwide Medicaid expansion.
The Hub is here to help long-term survivors navigate the headwinds of living with HIV.
Addressing a person's alcoholism can lead to increased condom use, and improve HIV medication adherence.
